Cargando…

The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists

The coronavirus disease 2019 (COVID-19) pandemic has elicited many health concerns, including the impact of the infection and vaccine on reproductive health. Although robust evidence demonstrates the safety of all available COVID-19 vaccines, misinformation and disinformation related to the vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Vernon, Veronica, Patel, Jaini, Cieri-Hutcherson, Nicole E., Arellano, Regina, Elmore, Hannah, Griffin, Brooke L., Mitzel, Kayla, Moyeno, Wandyenid Márquez, O’Connell, Mary Beth, Pelaccio, Karli, Lodise, Nicole M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Pharmacists Association®. Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831663/
https://www.ncbi.nlm.nih.gov/pubmed/36775738
http://dx.doi.org/10.1016/j.japh.2023.01.003
_version_ 1784867893076295680
author Vernon, Veronica
Patel, Jaini
Cieri-Hutcherson, Nicole E.
Arellano, Regina
Elmore, Hannah
Griffin, Brooke L.
Mitzel, Kayla
Moyeno, Wandyenid Márquez
O’Connell, Mary Beth
Pelaccio, Karli
Lodise, Nicole M.
author_facet Vernon, Veronica
Patel, Jaini
Cieri-Hutcherson, Nicole E.
Arellano, Regina
Elmore, Hannah
Griffin, Brooke L.
Mitzel, Kayla
Moyeno, Wandyenid Márquez
O’Connell, Mary Beth
Pelaccio, Karli
Lodise, Nicole M.
author_sort Vernon, Veronica
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic has elicited many health concerns, including the impact of the infection and vaccine on reproductive health. Although robust evidence demonstrates the safety of all available COVID-19 vaccines, misinformation and disinformation related to the vaccine continue to circulate. As accessible and essential health care workers, it is crucial that pharmacists are informed of the evidence related to effects of the COVID-19 infection and vaccinations on reproductive health care. Menstrual cycle changes have been noted owing to COVID-19 infection, pandemic stress, and COVID-19 vaccination. COVID-19 infection and vaccination have not been shown to influence female fertility, pregnancy rates, and lactation. The use of exogenous estrogen may further contribute to an increased risk of thromboembolism with COVID-19 infection, and differences in the risk of cerebral venous sinus thrombosis appear to exist between the types of vaccines. The benefits of COVID-19 vaccination outweigh any risks. Shared decision-making is necessary when discussing vaccination with patients. Pharmacists play a vital role in dispelling misinformation and disinformation related to the impact of COVID-19 illness and vaccination on reproductive health care.
format Online
Article
Text
id pubmed-9831663
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Pharmacists Association®. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-98316632023-01-11 The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists Vernon, Veronica Patel, Jaini Cieri-Hutcherson, Nicole E. Arellano, Regina Elmore, Hannah Griffin, Brooke L. Mitzel, Kayla Moyeno, Wandyenid Márquez O’Connell, Mary Beth Pelaccio, Karli Lodise, Nicole M. J Am Pharm Assoc (2003) Commentary The coronavirus disease 2019 (COVID-19) pandemic has elicited many health concerns, including the impact of the infection and vaccine on reproductive health. Although robust evidence demonstrates the safety of all available COVID-19 vaccines, misinformation and disinformation related to the vaccine continue to circulate. As accessible and essential health care workers, it is crucial that pharmacists are informed of the evidence related to effects of the COVID-19 infection and vaccinations on reproductive health care. Menstrual cycle changes have been noted owing to COVID-19 infection, pandemic stress, and COVID-19 vaccination. COVID-19 infection and vaccination have not been shown to influence female fertility, pregnancy rates, and lactation. The use of exogenous estrogen may further contribute to an increased risk of thromboembolism with COVID-19 infection, and differences in the risk of cerebral venous sinus thrombosis appear to exist between the types of vaccines. The benefits of COVID-19 vaccination outweigh any risks. Shared decision-making is necessary when discussing vaccination with patients. Pharmacists play a vital role in dispelling misinformation and disinformation related to the impact of COVID-19 illness and vaccination on reproductive health care. American Pharmacists Association®. Published by Elsevier Inc. 2023 2023-01-11 /pmc/articles/PMC9831663/ /pubmed/36775738 http://dx.doi.org/10.1016/j.japh.2023.01.003 Text en © 2023 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Vernon, Veronica
Patel, Jaini
Cieri-Hutcherson, Nicole E.
Arellano, Regina
Elmore, Hannah
Griffin, Brooke L.
Mitzel, Kayla
Moyeno, Wandyenid Márquez
O’Connell, Mary Beth
Pelaccio, Karli
Lodise, Nicole M.
The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists
title The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists
title_full The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists
title_fullStr The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists
title_full_unstemmed The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists
title_short The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists
title_sort impact of covid-19 on select considerations in patients of reproductive age: brief talking points for pharmacists
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831663/
https://www.ncbi.nlm.nih.gov/pubmed/36775738
http://dx.doi.org/10.1016/j.japh.2023.01.003
work_keys_str_mv AT vernonveronica theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT pateljaini theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT cierihutchersonnicolee theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT arellanoregina theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT elmorehannah theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT griffinbrookel theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT mitzelkayla theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT moyenowandyenidmarquez theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT oconnellmarybeth theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT pelacciokarli theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT lodisenicolem theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT vernonveronica impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT pateljaini impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT cierihutchersonnicolee impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT arellanoregina impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT elmorehannah impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT griffinbrookel impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT mitzelkayla impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT moyenowandyenidmarquez impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT oconnellmarybeth impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT pelacciokarli impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists
AT lodisenicolem impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists